Neupogen Pregnancy


  • Injection
  • Febrile neutropenia
  • In non-myeloid malignancies
  • In patients undergoing myeloablative chemotherapy followed by marrow transplantation; Prophylaxis Febrile neutropenia
  • In non-myeloid malignancies following myelosuppressive chemotherapy; Prophylaxis Febrile neutropenia
  • In patients with acute myeloid leukemia receiving chemotherapy; Prophylaxis Harvesting of peripheral blood stem cells Neutropenic disorder
  • Chronic (Severe)
Back to: Full Site Navigation

Is Neupogen (Filgrastim) safe during pregnancy or nursing?

The FDA category for this medication is C. It is advised that you: Weigh risks vs. benefits

Neupogen (Filgrastim) pregnancy info from our pharmacists

  • Upsides
  • No info available
  • Downsides
  • No info available
  • Tips
  • No info available
  • Risks
  • No info available
Source: FDA package insert